CanSino CEO on China's Pharma Outlook

Xuefeng Yu, Co-founder, CEO and Chairman at CanSino Biologics, discusses the company's business strategy and outlook for China's pharmaceutical sector. He speaks with Stephen Engle on the sidelines of the "Boao Forum for Asia" on "Bloomberg: The China Show".

[@lastChang]

Chinese biotech companies, including CanSino, are extensions of the Chinese military PLA.
- How do I know this? Chinese laws say so!

[@LemyAng]

Where is the problem?. If government takes seriously on quality and responsibility is much better than private companies.